FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2227852935> ?p ?o ?g. }

• W2227852935 endingPage "1095" @default.
• W2227852935 startingPage "1088" @default.
• W2227852935 abstract "Background A substantial proportion of patients do not respond to cardiac resynchronization therapy (CRT). Various echocardiographic and biochemical markers including collagen turnover biomarkers were suggested to predict CRT results. However, pathological significance of collagen turnover biomarkers in CRT remains controversial. Objective The aim of the present study was to evaluate the relationship between levels of collagen turnover biomarkers (amino-terminal propeptide of procollagen type I and amino-terminal propeptide of procollagen type III [PIIINP]), N-terminal of the prohormone brain natriuretic peptide (NT-proBNP), high-sensitivity C-reactive protein, and matrix metalloproteinases (metalloproteinase-2 and metalloproteinase-9) and echocardiographic response to CRT and clinical outcomes. Methods The study population consisted of patients enrolled in the Triple Site Versus Standard Cardiac Resynchronization Therapy trial. Blood samples were obtained before implantation of a CRT with defibrillator. The levels of PIIINP, amino-terminal propeptide of procollagen type I, metalloproteinase-2, and metalloproteinase-9 were determined using commercially available ELISA kits. High-sensitivity C-reactive protein and NT-proBNP levels were determined in a standard way. Results Samples were collected from 74 of 100 enrolled patients. The multivariate logistic regression analysis demonstrated that low PIIINP levels (odds ratio [OR] 3.56; 95% confidence interval [CI] 1.23–10.24; P = .017) and baseline ejection fraction (OR 2.14; 95% CI 1.11–4.11; P = .02) were favorably associated with echocardiographic response. PIIINP and NT-proBNP levels appeared to be independent predictors of all-cause mortality (PIIINP: OR 3.11; 95% CI 1.21–7.89; P = .033; NT-proBNP: OR 2.05; 95% CI 1.11–4.96; P = .039) and risk of major cardiac adverse event (PIIINP: OR 3.56; 95% CI 1.53–9.15; P = .007; NT-proBNP: OR 4.51; 95% CI 1.75–11.6; P = .001). PIIINP levels showed significant additive value in predicting mortality as compared with NT-proBNP levels, but they were not superior to ejection fraction in predicting response. Survival analysis with cutoff values identified by receiver operating characteristic analysis confirmed a significant benefit associated with low baseline PIIINP levels. Conclusion Low PIIINP levels are associated with favorable echocardiographic response and long-term survival in CRT recipients. A substantial proportion of patients do not respond to cardiac resynchronization therapy (CRT). Various echocardiographic and biochemical markers including collagen turnover biomarkers were suggested to predict CRT results. However, pathological significance of collagen turnover biomarkers in CRT remains controversial. The aim of the present study was to evaluate the relationship between levels of collagen turnover biomarkers (amino-terminal propeptide of procollagen type I and amino-terminal propeptide of procollagen type III [PIIINP]), N-terminal of the prohormone brain natriuretic peptide (NT-proBNP), high-sensitivity C-reactive protein, and matrix metalloproteinases (metalloproteinase-2 and metalloproteinase-9) and echocardiographic response to CRT and clinical outcomes. The study population consisted of patients enrolled in the Triple Site Versus Standard Cardiac Resynchronization Therapy trial. Blood samples were obtained before implantation of a CRT with defibrillator. The levels of PIIINP, amino-terminal propeptide of procollagen type I, metalloproteinase-2, and metalloproteinase-9 were determined using commercially available ELISA kits. High-sensitivity C-reactive protein and NT-proBNP levels were determined in a standard way. Samples were collected from 74 of 100 enrolled patients. The multivariate logistic regression analysis demonstrated that low PIIINP levels (odds ratio [OR] 3.56; 95% confidence interval [CI] 1.23–10.24; P = .017) and baseline ejection fraction (OR 2.14; 95% CI 1.11–4.11; P = .02) were favorably associated with echocardiographic response. PIIINP and NT-proBNP levels appeared to be independent predictors of all-cause mortality (PIIINP: OR 3.11; 95% CI 1.21–7.89; P = .033; NT-proBNP: OR 2.05; 95% CI 1.11–4.96; P = .039) and risk of major cardiac adverse event (PIIINP: OR 3.56; 95% CI 1.53–9.15; P = .007; NT-proBNP: OR 4.51; 95% CI 1.75–11.6; P = .001). PIIINP levels showed significant additive value in predicting mortality as compared with NT-proBNP levels, but they were not superior to ejection fraction in predicting response. Survival analysis with cutoff values identified by receiver operating characteristic analysis confirmed a significant benefit associated with low baseline PIIINP levels. Low PIIINP levels are associated with favorable echocardiographic response and long-term survival in CRT recipients." @default.
• W2227852935 created "2016-06-24" @default.
• W2227852935 creator A5006498031 @default.
• W2227852935 creator A5014806250 @default.
• W2227852935 creator A5024196642 @default.
• W2227852935 creator A5052492635 @default.
• W2227852935 creator A5054860352 @default.
• W2227852935 creator A5069525541 @default.
• W2227852935 creator A5076713156 @default.
• W2227852935 creator A5079025181 @default.
• W2227852935 creator A5080509880 @default.
• W2227852935 creator A5085088749 @default.
• W2227852935 date "2016-05-01" @default.
• W2227852935 modified "2023-10-18" @default.
• W2227852935 title "Prognostic value of collagen turnover biomarkers in cardiac resynchronization therapy: A subanalysis of the TRUST CRT randomized trial population" @default.
• W2227852935 cites W1676600749 @default.
• W2227852935 cites W1951743184 @default.
• W2227852935 cites W1971681610 @default.
• W2227852935 cites W1973027095 @default.
• W2227852935 cites W1974796215 @default.
• W2227852935 cites W1982690035 @default.
• W2227852935 cites W1989037644 @default.
• W2227852935 cites W2019898117 @default.
• W2227852935 cites W2023484468 @default.
• W2227852935 cites W2024751299 @default.
• W2227852935 cites W2027082110 @default.
• W2227852935 cites W2030276811 @default.
• W2227852935 cites W2049609455 @default.
• W2227852935 cites W2050862994 @default.
• W2227852935 cites W2051435139 @default.
• W2227852935 cites W2065027534 @default.
• W2227852935 cites W2067587023 @default.
• W2227852935 cites W2067825157 @default.
• W2227852935 cites W2074958057 @default.
• W2227852935 cites W2077769318 @default.
• W2227852935 cites W2084848130 @default.
• W2227852935 cites W2092795012 @default.
• W2227852935 cites W2094666810 @default.
• W2227852935 cites W2098336403 @default.
• W2227852935 cites W2100056258 @default.
• W2227852935 cites W2103509213 @default.
• W2227852935 cites W2121399908 @default.
• W2227852935 cites W2128819617 @default.
• W2227852935 cites W2132254666 @default.
• W2227852935 cites W2138173733 @default.
• W2227852935 cites W2144944342 @default.
• W2227852935 cites W2148075660 @default.
• W2227852935 cites W2152517370 @default.
• W2227852935 cites W2335329924 @default.
• W2227852935 cites W2614153041 @default.
• W2227852935 cites W604783079 @default.
• W2227852935 doi "https://doi.org/10.1016/j.hrthm.2015.12.036" @default.
• W2227852935 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26776557" @default.
• W2227852935 hasPublicationYear "2016" @default.
• W2227852935 type Work @default.
• W2227852935 sameAs 2227852935 @default.
• W2227852935 citedByCount "11" @default.
• W2227852935 countsByYear W22278529352016 @default.
• W2227852935 countsByYear W22278529352018 @default.
• W2227852935 countsByYear W22278529352019 @default.
• W2227852935 countsByYear W22278529352020 @default.
• W2227852935 countsByYear W22278529352022 @default.
• W2227852935 countsByYear W22278529352023 @default.
• W2227852935 crossrefType "journal-article" @default.
• W2227852935 hasAuthorship W2227852935A5006498031 @default.
• W2227852935 hasAuthorship W2227852935A5014806250 @default.
• W2227852935 hasAuthorship W2227852935A5024196642 @default.
• W2227852935 hasAuthorship W2227852935A5052492635 @default.
• W2227852935 hasAuthorship W2227852935A5054860352 @default.
• W2227852935 hasAuthorship W2227852935A5069525541 @default.
• W2227852935 hasAuthorship W2227852935A5076713156 @default.
• W2227852935 hasAuthorship W2227852935A5079025181 @default.
• W2227852935 hasAuthorship W2227852935A5080509880 @default.
• W2227852935 hasAuthorship W2227852935A5085088749 @default.
• W2227852935 hasConcept C126322002 @default.
• W2227852935 hasConcept C156957248 @default.
• W2227852935 hasConcept C164705383 @default.
• W2227852935 hasConcept C185592680 @default.
• W2227852935 hasConcept C2775846464 @default.
• W2227852935 hasConcept C2775915353 @default.
• W2227852935 hasConcept C2776034619 @default.
• W2227852935 hasConcept C2778198053 @default.
• W2227852935 hasConcept C2781197716 @default.
• W2227852935 hasConcept C2908647359 @default.
• W2227852935 hasConcept C44249647 @default.
• W2227852935 hasConcept C55493867 @default.
• W2227852935 hasConcept C64348721 @default.
• W2227852935 hasConcept C71924100 @default.
• W2227852935 hasConcept C78085059 @default.
• W2227852935 hasConcept C99454951 @default.
• W2227852935 hasConceptScore W2227852935C126322002 @default.
• W2227852935 hasConceptScore W2227852935C156957248 @default.
• W2227852935 hasConceptScore W2227852935C164705383 @default.
• W2227852935 hasConceptScore W2227852935C185592680 @default.
• W2227852935 hasConceptScore W2227852935C2775846464 @default.
• W2227852935 hasConceptScore W2227852935C2775915353 @default.
• W2227852935 hasConceptScore W2227852935C2776034619 @default.
• W2227852935 hasConceptScore W2227852935C2778198053 @default.

• next